SARS-CoV M Protein (C-Term) Peptide

Details for Product No. ABIN1382275, Supplier: Log in to see
Protein Name
Protein Region
C-Term
Origin
Virus
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-Matrix (M) (C-Term) antibody (ABIN1030640)
Characteristics 13 amino acids near the carboxy terminus of SARS M protein.
Virus
Application Notes SARS matrix peptide is used for blocking the activity of the SARS matrix.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Yonezawa, Tokunaga, Oshiro, Yoshino: "Raptor, a binding partner of target of rapamycin." in: Biochemical and biophysical research communications, Vol. 313, Issue 2, pp. 437-41, 2003 (PubMed).

Marra, Jones, Astell, Holt, Brooks-Wilson, Butterfield, Khattra, Asano, Barber, Chan, Cloutier, Coughlin, Freeman, Girn, Griffith, Leach, Mayo, McDonald, Montgomery, Pandoh, Petrescu, Robertson et al.: "The Genome sequence of the SARS-associated coronavirus. ..." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1399-404, 2003 (PubMed).

Hara, Yonezawa, Weng, Kozlowski, Belham, Avruch: "Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism." in: The Journal of biological chemistry, Vol. 273, Issue 23, pp. 14484-94, 1998 (PubMed).